These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 1759828)

  • 1. Emergence of fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli in subjects from Finland.
    Rautelin H; Renkonen OV; Kosunen TU
    Antimicrob Agents Chemother; 1991 Oct; 35(10):2065-9. PubMed ID: 1759828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial susceptibilities of Campylobacter strains isolated from Finnish subjects infected domestically or from those infected abroad.
    Rautelin H; Vierikko A; Hänninen ML; Vaara M
    Antimicrob Agents Chemother; 2003 Jan; 47(1):102-5. PubMed ID: 12499176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A nationwide study of Campylobacter jejuni and Campylobacter coli bacteremia in Finland over a 10-year period, 1998-2007, with special reference to clinical characteristics and antimicrobial susceptibility.
    Feodoroff B; Lauhio A; Ellström P; Rautelin H
    Clin Infect Dis; 2011 Oct; 53(8):e99-e106. PubMed ID: 21921217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial susceptibilities of Campylobacter jejuni and Campylobacter coli isolated in Sweden: a 10-year follow-up report.
    Sjögren E; Kaijser B; Werner M
    Antimicrob Agents Chemother; 1992 Dec; 36(12):2847-9. PubMed ID: 1482158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quinolone resistance in clinical strains of Campylobacter jejuni and Campylobacter coli.
    Harnett N; McLeod S; Yong YA; Hewitt C; Vearncombe M; Krishnan C
    J Antimicrob Chemother; 1995 Jul; 36(1):269-70. PubMed ID: 8537280
    [No Abstract]   [Full Text] [Related]  

  • 6. Norfloxacin resistance in Campylobacter jejuni and Campylobacter coli isolates from Swedish patients.
    Sjögren E; Lindblom GB; Kaijser B
    J Antimicrob Chemother; 1997 Aug; 40(2):257-61. PubMed ID: 9301992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial susceptibilities of Campylobacter jejuni and coli by using E-test in Taiwan.
    Li CC; Chiu CH; Wu JL; Huang YC; Lin TY
    Scand J Infect Dis; 1998; 30(1):39-42. PubMed ID: 9670357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial susceptibilities of multidrug-resistant Campylobacter jejuni and C. coli strains: in vitro activities of 20 antimicrobial agents.
    Lehtopolku M; Nakari UM; Kotilainen P; Huovinen P; Siitonen A; Hakanen AJ
    Antimicrob Agents Chemother; 2010 Mar; 54(3):1232-6. PubMed ID: 20038624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug resistance in Campylobacter jejuni, C coli, and C lari isolated from humans in north west England and Wales, 1997.
    Thwaites RT; Frost JA
    J Clin Pathol; 1999 Nov; 52(11):812-4. PubMed ID: 10690169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence of resistance to erythromycin and fluoroquinolones in thermotolerant Campylobacter strains isolated from feces 1987-1991.
    Reina J; Borrell N; Serra A
    Eur J Clin Microbiol Infect Dis; 1992 Dec; 11(12):1163-6. PubMed ID: 1291314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antimicrobial susceptibilities of Campylobacter sp strains isolated from humans in 2005 to 2006 in Bielsko-Biala Region, Poland].
    Wardak S; Szych J; Duda U
    Med Dosw Mikrobiol; 2007; 59(1):43-9. PubMed ID: 17601030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial susceptibilities of Campylobacter strains isolated from broilers in the southern part of Japan from 1995 to 1999.
    Chuma T; Ikeda T; Maeda T; Niwa H; Okamoto K
    J Vet Med Sci; 2001 Sep; 63(9):1027-9. PubMed ID: 11642273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activities of new fluoroquinolones against Campylobacter jejuni and Campylobacter coli isolates obtained from humans in 1980 to 1982 and 1997 to 2001.
    Krausse R; Ullmann U
    Antimicrob Agents Chemother; 2003 Sep; 47(9):2946-50. PubMed ID: 12936999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance to bile salts and sodium deoxycholate in macrolide- and fluoroquinolone-susceptible and resistant Campylobacter jejuni and Campylobacter coli strains.
    Mavri A; Smole Možina S
    Microb Drug Resist; 2013 Jun; 19(3):168-74. PubMed ID: 23289436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and antimicrobial resistance of Campylobacter jejuni and Campylobacter coli isolated from children and environmental sources in urban and suburban areas.
    Szczepanska B; Andrzejewska M; Spica D; Klawe JJ
    BMC Microbiol; 2017 Apr; 17(1):80. PubMed ID: 28376713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro susceptibilities of Campylobacter jejuni and Campylobacter coli to azithromycin and erythromycin.
    Taylor DE; Chang N
    Antimicrob Agents Chemother; 1991 Sep; 35(9):1917-8. PubMed ID: 1659309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of disc diffusion and agar dilution methods for antibiotic susceptibility testing of Campylobacter jejuni subsp. jejuni and Campylobacter coli.
    Gaudreau C; Gilbert H
    J Antimicrob Chemother; 1997 Jun; 39(6):707-12. PubMed ID: 9222038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial susceptibilities of Campylobacter jejuni and Campylobacter coli strains isolated from two early stages of poultry production.
    Pérez-Boto D; García-Peña FJ; Abad-Moreno JC; Echeita MA
    Microb Drug Resist; 2013 Aug; 19(4):323-30. PubMed ID: 23391315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe diarrhoea caused by highly ciprofloxacin-susceptible Campylobacter isolates.
    Feodoroff FB; Lauhio AR; Sarna SJ; Hänninen ML; Rautelin HI
    Clin Microbiol Infect; 2009 Feb; 15(2):188-92. PubMed ID: 19154485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluoroquinolone resistance in Campylobacter jejuni isolates in travelers returning to Finland: association of ciprofloxacin resistance to travel destination.
    Hakanen A; Jousimies-Somer H; Siitonen A; Huovinen P; Kotilainen P
    Emerg Infect Dis; 2003 Feb; 9(2):267-70. PubMed ID: 12604004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.